Skip to Content

Ingen Technologies Inc IGNT

Morningstar Rating
$0.00 0.00 (46.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IGNT is trading at a 732% premium.
Price
$0.00
Fair Value
$4.85
Uncertainty
Extreme
1-Star Price
$1.26
5-Star Price
Economic Moat
Rknn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IGNT is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$244,033.28
Volume/Avg
537 / 5,824

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Ingen Technologies Inc manufactures proprietary medical equipment and has developed markets for patients suffering with Chronic Obstructive Pulmonary Disease and who require oxygen therapy through home healthcare, hospitals, military and government based medical facilities. It manufactures oxygen flow meters and nasal cannulas under the trademark name Oxyview and Smart.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees
5

Valuation

Metric
IGNT
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
IGNT
Quick Ratio
0.00
Current Ratio
0.06
Interest Coverage
−0.38
Quick Ratio
No chart available

Profitability

Metric
IGNT
Return on Assets (Normalized)
−361.68%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
TzgpfdspNbykbb$183.1 Bil
Stryker Corp
SYK
CfkllxtqyYzcwr$126.3 Bil
Boston Scientific Corp
BSX
XnpmvfpjNchwcw$110.1 Bil
Medtronic PLC
MDT
GrzzmbjfBstbr$100.9 Bil
Edwards Lifesciences Corp
EW
LxrqlygsjXlknsc$37.6 Bil
DexCom Inc
DXCM
PwkjgfbvKnryk$25.6 Bil
Koninklijke Philips NV ADR
PHG
HzybmkyxvBpxnbm$24.1 Bil
Steris PLC
STE
KhcgspbQshrppq$23.0 Bil
Zimmer Biomet Holdings Inc
ZBH
HcdhtcvccWftj$22.9 Bil
Align Technology Inc
ALGN
DcbybwfdPnmygk$16.6 Bil

Sponsor Center